» Articles » PMID: 30573112

Human Atrial Fibrillation Drivers Resolved With Integrated Functional And Structural Imaging to Benefit Clinical Mapping

Abstract

Objectives: This study sought to improve atrial fibrillation (AF) driver identification by integrating clinical multielectrode mapping with driver fingerprints defined by high-resolution ex vivo 3-dimensional (3D) functional and structural imaging.

Background: Clinical multielectrode mapping of AF drivers suffers from variable contact, signal processing, and structural complexity within the 3D human atrial wall, raising questions on the validity of such drivers.

Methods: Sustained AF was mapped in coronary-perfused explanted human hearts (n = 11) with transmural near-infrared optical mapping (∼0.3 mm resolution). Simultaneously, custom FIRMap catheters (∼9 × 9 mm resolution) mapped endocardial and epicardial surfaces, which were analyzed by Focal Impulse and Rotor Mapping activation and Rotational Activity Profile (Abbott Labs, Chicago, Illinois). Functional maps were integrated with contrast-enhanced cardiac magnetic resonance imaging (∼0.1 mm resolution) analysis of 3D fibrosis architecture.

Results: During sustained AF, near-infrared optical mapping identified 1 to 2 intramural, spatially stable re-entrant AF drivers per heart. Driver targeted ablation affecting 2.2 ± 1.1% of the atrial surface terminated and prevented AF. Driver regions had significantly higher phase singularity density and dominant frequency than neighboring nondriver regions. Focal Impulse and Rotor Mapping had 80% sensitivity to near-infrared optical mapping-defined driver locations (16 of 20), and matched 14 of 20 driver visualizations: 10 of 14 re-entries seen with Rotational Activity Profile; and 4 of 6 breakthrough/focal patterns. Focal Impulse and Rotor Mapping detected 1.1 ± 0.9 false-positive rotational activity profiles per recording, but these regions had lower intramural contrast-enhanced cardiac magnetic resonance imaging fibrosis than did driver regions (14.9 ± 7.9% vs. 23.2 ± 10.5%; p < 0.005).

Conclusions: The study revealed that both re-entrant and breakthrough/focal AF driver patterns visualized by surface-only clinical multielectrodes can represent projections of 3D intramural microanatomic re-entries. Integration of multielectrode mapping and 3D fibrosis analysis may enhance AF driver detection, thereby improving the efficacy of driver-targeted ablation.

Citing Articles

Are drivers recurring or ephemeral? observations from serial mapping of persistent atrial fibrillation.

Hunt B, Kwan E, Paccione E, Orkild B, Yazaki K, Bergquist J Europace. 2024; 26(11).

PMID: 39418392 PMC: 11542584. DOI: 10.1093/europace/euae269.


Ibrutinib and atrial fibrillation: An in-depth review of clinical implications and management strategies.

Mohyeldin M, Shrivastava S, Allu S World J Cardiol. 2024; 16(5):269-273.

PMID: 38817647 PMC: 11135330. DOI: 10.4330/wjc.v16.i5.269.


Isolated Perfused Hearts for Cardiovascular Research: An Old Dog with New Tricks.

Yang T, Liu Z, Shu S, Chen Z, Hua X, Song J J Cardiovasc Transl Res. 2024; 17(5):1207-1217.

PMID: 38717725 PMC: 11519150. DOI: 10.1007/s12265-024-10517-7.


Spatially Conserved Spiral Wave Activity During Human Atrial Fibrillation.

Rappel W, Baykaner T, Zaman J, Ganesan P, Rogers A, Narayan S Circ Arrhythm Electrophysiol. 2024; 17(3):e012041.

PMID: 38348685 PMC: 10950516. DOI: 10.1161/CIRCEP.123.012041.


Chamber-specific wall thickness features in human atrial fibrillation.

Zhao J, Kennelly J, Nalar A, Kulathilaka A, Sharma R, Bai J Interface Focus. 2023; 13(6):20230044.

PMID: 38106912 PMC: 10722209. DOI: 10.1098/rsfs.2023.0044.


References
1.
Zahid S, Cochet H, Boyle P, Schwarz E, Whyte K, Vigmond E . Patient-derived models link re-entrant driver localization in atrial fibrillation to fibrosis spatial pattern. Cardiovasc Res. 2016; 110(3):443-54. PMC: 4872878. DOI: 10.1093/cvr/cvw073. View

2.
Rodrigo M, Climent A, Liberos A, Fernandez-Aviles F, Berenfeld O, Atienza F . Technical Considerations on Phase Mapping for Identification of Atrial Reentrant Activity in Direct- and Inverse-Computed Electrograms. Circ Arrhythm Electrophysiol. 2017; 10(9). DOI: 10.1161/CIRCEP.117.005008. View

3.
Miller J, Kalra V, Das M, Jain R, Garlie J, Brewster J . Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry. J Am Coll Cardiol. 2017; 69(10):1247-1256. DOI: 10.1016/j.jacc.2016.11.079. View

4.
Vijayakumar R, Vasireddi S, Cuculich P, Faddis M, Rudy Y . Methodology Considerations in Phase Mapping of Human Cardiac Arrhythmias. Circ Arrhythm Electrophysiol. 2016; 9(11). PMC: 5137810. DOI: 10.1161/CIRCEP.116.004409. View

5.
Honarbakhsh S, Schilling R, Dhillon G, Ullah W, Keating E, Providencia R . A Novel Mapping System for Panoramic Mapping of the Left Atrium: Application to Detect and Characterize Localized Sources Maintaining Atrial Fibrillation. JACC Clin Electrophysiol. 2018; 4(1):124-134. PMC: 5777816. DOI: 10.1016/j.jacep.2017.09.177. View